The Diagnosis a Reporter Leaves Unspoken: Surfacing Frozen Tumor Features for Brain-Tumor MRI Reporting

• URL: http://arxiv.org/abs/2609.02411v1
• Date: Wed, 02 Sep 2026 10:29:53 GMT
• Title: The Diagnosis a Reporter Leaves Unspoken: Surfacing Frozen Tumor Features for Brain-Tumor MRI Reporting
• Abstract summary: A capable brain-MRI report generator can still be diagnostically silent.<n>NeuroFusion surfaces this latent signal rather than overriding it.<n>Two board-certified neurologists independently rated NeuroFusion highest in every tumour type.
• Score: 0.9283653948385912
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: A capable brain-MRI report generator can still be, in effect, diagnostically silent. When a multi-chain chain-of-thought (CoT) reporter built on a medical Mistral-7B backbone is evaluated on held-out cohorts, it names most meningiomas and almost all metastases "glioma" (diagnosis recall 0.44/0.07). Yet the answer is not absent from the model: a supervised linear probe applied to its frozen segmentation features recovers the three tumour cohorts at 0.82 macro-F$_1$ (5-fold cross-validation; chance $\approx$0.33). We introduce NeuroFusion, an assistive reporter that surfaces this latent signal rather than overriding it: discriminative field-classifier heads over per-lesion features condition a fast, single-pass draft-then-review decoder on their committed outputs. Built on the identical Mistral backbone, this restores the diagnosis (meningioma 0.92, metastasis 0.75) and wins 8 of 9 prose-content comparisons across three held-out cohorts (RaTEScore, RadGraph-F$_1$, GREEN; Holm-corrected paired BCa), with no significant loss on the ninth, at 5-6x lower latency ($\approx$80 vs. 457 s/case). A controlled negative result sharpens the mechanism: a learned diagnosis pin that overrides the decoder instead of merely informing it collapses out-of-distribution metastasis recall to 0.03. Grammar-constrained decoding keeps 92.3% of records schema-valid, making every sentence entailment-checkable (7.5% contradicted vs. 36.8% for the direct baseline). In a blinded nine-case pilot, two board-certified neurologists independently rated NeuroFusion highest in every tumour type, the only system with zero critical errors, and gave it the top-rated sign-off in eight of nine cases (six outright, two ties).

Related papers

• MIRROR: Multimodal Intelligent Radiology Reasoning and Observation Reporter [1.3106404792425626]
  MIRROR is a research prototype built to separate failures from successes.<n>It chains a multi-label classifier, a Grad-CAM localizer, and a report writer that receives the labels, probabilities, and regions but never the image.<n>A MIRROR report's findings are auditable against the probability vector, while the sentences framing them are ordinary generated text.
  arXiv  Detail & Related papers  (2026-08-17T15:25:38Z)
• Auditable agentic AI for evidence-grounded thyroid ultrasound diagnosis and reporting [59.709162055944915]
  ThyroidXAgent is an agentic AI system that coordinates specialized diagnostic tools and stores their outputs as an auditable case-level evidence record.<n>It was evaluated on 28,458 non-overlapping test cases, including 8,721 cases from 35 centres in the private NHC-MISD-TUS cohort.<n>It achieved a mean Dice score of 87.21 percent for segmentation and a mean AUROC of 0.9466 for benign-malignant classification.
  arXiv  Detail & Related papers  (2026-08-12T21:02:59Z)
• NeuroMosaic: Anatomically Grounded Multimodal Large Language Modeling for Molecularly Aware Glioma Reasoning from 3D MRI and Clinical Narratives [0.7742420215649948]
  We present NeuroMosaic, a 3D multimodal language model that converts multi-sequence brain MRI into anatomy-indexed regional tokens.<n>The architecture combines a multi-resolution volumetric tokenizer, a neuroanatomical graph router, a molecular concept memory, and selective risk control.
  arXiv  Detail & Related papers  (2026-08-04T06:26:50Z)
• RareLens: Towards End-to-End Rare Disease Care via Aligning Divergent Large Language Model Reasoning [42.80742579670377]
  RareLens is a system that supports clinical decision-making across the entire rare disease trajectory.<n>Developed and evaluated on RareBench, a real-world dataset of 157,525 cases spanning all 33 Orphanet categories and more than 7,000 conditions.<n>It achieved an area under the curve of 0.917 for screening and top-1 accuracies of 65.5% and 89.8% for diagnosis and treatment.
  arXiv  Detail & Related papers  (2026-07-25T16:58:10Z)
• Post-Operative Glioma Segmentation via Loss Stabilization, Normalization and Subspace Attention [46.03321798937855]
  We show that the standard Generalized Dice Loss (GDL) is unstable under domain shift.<n>We propose a Subspace-Aware Class Attention (SACA) module that re-calibrates the bottleneck features and raises Enhancing Tumor (ET) sensitivity by 8%.
  arXiv  Detail & Related papers  (2026-07-23T09:59:30Z)
• Monte Carlo Dropout Uncertainty and Entropy-Thresholded Selective Prediction for Architecture-Agnostic Brain Tumor MRI Triage [0.0]
  This study proposes an uncertainty-first pipeline for four-class brain tumor MRI.<n>It reads predictive uncertainty from Monte Carlo (MC) Dropout over T = 20 passes and turns the resulting entropy into an explicit rule for deferring uncertain cases to a radiologist.
  arXiv  Detail & Related papers  (2026-07-15T06:21:17Z)
• CoMNeT: A MedNeXt-CorrDiff Framework for Volumetric Brain Tumor Segmentation [1.2048008992808203]
  We show that combining a modern 3D convolutional segmentation model with corrective diffusion-based refinement and ensembling improves volumetric glioma segmentation.<n>We propose CoMNeT, a MedNeXt-CorrDiff framework that uses four MRI modalities as input and predicts ET, TC, and whole tumor.<n>Using five-fold cross-validation, CoMNeT achieved the highest Dice score for most tumor regions, with ET, TC, WT, and average Dice scores of 0.7543 +/- 0.0261, 0.6806 +/- 0.0166, 0.9049 +/- 0.0128, and 0.7798 +/- 0.0184
  arXiv  Detail & Related papers  (2026-06-13T13:51:10Z)
• DRBD-Mamba for Robust and Efficient Brain Tumor Segmentation with Analytical Insights [54.87947751720332]
  Accurate brain tumor segmentation is significant for clinical diagnosis and treatment.<n>Mamba-based State Space Models have demonstrated promising performance.<n>We propose a dual-resolution bi-directional Mamba that captures multi-scale long-range dependencies with minimal computational overhead.
  arXiv  Detail & Related papers  (2025-10-16T07:31:21Z)
• Brain Tumor Classification on MRI in Light of Molecular Markers [56.99710477905796]
  Co-deletion of the 1p/19q gene is associated with clinical outcomes in low-grade gliomas.<n>This study aims to utilize a specially MRI-based convolutional neural network for brain cancer detection.
  arXiv  Detail & Related papers  (2024-09-29T07:04:26Z)
• Learning to diagnose cirrhosis from radiological and histological labels with joint self and weakly-supervised pretraining strategies [62.840338941861134]
  We propose to leverage transfer learning from large datasets annotated by radiologists, to predict the histological score available on a small annex dataset. We compare different pretraining methods, namely weakly-supervised and self-supervised ones, to improve the prediction of the cirrhosis. This method outperforms the baseline classification of the METAVIR score, reaching an AUC of 0.84 and a balanced accuracy of 0.75.
  arXiv  Detail & Related papers  (2023-02-16T17:06:23Z)
• Handling Missing MRI Input Data in Deep Learning Segmentation of Brain Metastases: A Multi-Center Study [1.4463443378902883]
  A deep learning based segmentation model for automatic segmentation of brain metastases, named DropOut, was trained on multi-sequence MRI. The segmentation results were compared with the performance of a state-of-the-art DeepLabV3 model. The DropOut model showed a significantly higher score compared to the DeepLabV3 model.
  arXiv  Detail & Related papers  (2019-12-27T02:49:45Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.